Emphysema |
Pulmonary Emphysema |
Clinical Trial: Yoga for Treating Shortness of Breath in Chronic Obstructive Pulmonary Disease (COPD)
This study has been completed.
|
Purpose
The purpose of this study is to evaluate the safety and effectiveness of yoga in reducing shortness of breath in people with chronic obstructive pulmonary disease (COPD). Patients in this study must have moderate to severe COPD and be primarily limited by shortness of breath.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Pulmonary Disease, Chronic Obstructive Lung Diseases, Obstructive Pulmonary Emphysema Chronic Bronchitis | Behavior: yoga | Phase I Phase II |
MedlinePlus related topics: Bronchitis; COPD (Chronic Obstructive Pulmonary Disease); Emphysema
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title: Efficacy of Yoga for Self-Management of Dyspnea in COPD
Expected Total Enrollment: 36
Study start: January 2003; Study completion: July 2004
Management of dyspnea (shortness of breath) is a major concern for patients with COPD. The efficacy of complementary exercises to manage dyspnea is unknown. Complementary exercises may be more congruent with patients' lifestyles and values than traditional exercise programs and can be adapted to changes in illness severity and disability. Yoga practice is a complementary therapy that people use to manage their dyspnea. The aims of this study are to: 1) develop a safe and feasible yoga program for patients with COPD; 2) test the efficacy of this program; and 3) determine whether physical performance, psychological well being, and health-related quality of life are positively affected by yoga practice.
Patients in this study will be randomized to receive yoga training or usual care for 12 weeks. Patients will be evaluated at study entry, after each session, and immediately after the training program.
Eligibility
Ages Eligible for Study: 40 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion criteria:
- Able to commit to a 12-week yoga class in San Francisco, California
- Moderate to severe COPD, clinically stable for at least 1 month prior to study entry
- Forced Expiratory Volume at one minute (FEV1) < 49% predicted after inhaled bronchodilator
- Activities of daily living limited by shortness of breath
- Ability to speak English and sign consent
- Patients receiving supplemental oxygen will be acceptable if their O2 saturation can be maintained at > 85% on < 6 L/min of nasal oxygen
Exclusion criteria:
- Symptomatic illness (e.g., cancer, left heart failure, ischemic heart disease, neuromuscular disease, psychiatric illness)
- Formal pulmonary rehabilitation training within 1 year prior to study entry
Location Information
California
University of California, San Francisco, California, United States
Virginia Carrieri-Kohlman, RN, DNSc, Principal Investigator, University of California, San Francisco
More Information
Record last reviewed: November 2004
Last Updated: November 9, 2004
Record first received: January 16, 2003
ClinicalTrials.gov Identifier: NCT00051792
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- A1AD Related Emphysema (American Lung Association)
- Alpha-1 Related Emphysema (American Lung Association)

Not Signed In -

